EphB2 Activity Plays a Pivotal Role in Pediatric Medulloblastoma Cell Adhesion and Invasion
Overview
Authors
Affiliations
Eph/ephrin signaling has been implicated in various types of key cancer-enhancing processes, like migration, proliferation, and angiogenesis. In medulloblastoma, invading tumor cells characteristically lead to early recurrence and a decreased prognosis. Based on kinase-activity profiling data published recently, we hypothesized a key role for the Eph/ephrin signaling system in medulloblastoma invasion. In primary medulloblastoma samples, a significantly higher expression of EphB2 and the ligand ephrin-B1 was observed compared with normal cerebellum. Furthermore, medulloblastoma cell lines showed high expression of EphA2, EphB2, and EphB4. Stimulation of medulloblastoma cells with ephrin-B1 resulted in a marked decrease in in vitro cell adhesion and an increase in the invasion capacity of cells expressing high levels of EphB2. The cell lines that showed an ephrin-B1-induced phenotype possessed increased levels of phosphorylated EphB2 and, to a lesser extent, EphB4 after stimulation. Knockdown of EphB2 expression by short hairpin RNA completely abolished ephrin ligand-induced effects on adhesion and migration. Analysis of signal transduction identified p38, Erk, and mTOR as downstream signaling mediators potentially inducing the ephrin-B1 phenotype. In conclusion, the observed deregulation of Eph/ephrin expression in medulloblastoma enhances the invasive phenotype, suggesting a potential role in local tumor cell invasion and the formation of metastases.
Development of an orthotopic medulloblastoma zebrafish model for rapid drug testing.
van Bree N, Oppelt A, Lindstrom S, Zhou L, Boutin L, Coyle B Neuro Oncol. 2024; 27(3):779-794.
PMID: 39383211 PMC: 11889719. DOI: 10.1093/neuonc/noae210.
Xu S, Zheng Y, Ye M, Shen T, Zhang D, Li Z BMC Cancer. 2024; 24(1):1064.
PMID: 39198775 PMC: 11351591. DOI: 10.1186/s12885-024-12843-0.
Chatzikalil E, Stergiou I, Papadakos S, Konstantinidis I, Theocharis S Int J Mol Sci. 2024; 25(7).
PMID: 38612645 PMC: 11011407. DOI: 10.3390/ijms25073834.
Bora Yildiz C, Kundu T, Gehrmann J, Koesling J, Ravaei A, Wolff P Epigenetics Chromatin. 2023; 16(1):42.
PMID: 37880732 PMC: 10601256. DOI: 10.1186/s13072-023-00516-4.
A preliminary study on the mechanism of VASH2 in childhood medulloblastoma.
Liu W, Fu Y, Wang M, Zhao J, Chen J, Wang Y Sci Rep. 2023; 13(1):17153.
PMID: 37821528 PMC: 10567924. DOI: 10.1038/s41598-023-42869-6.